Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 59
Filter
1.
J Appl Microbiol ; 119(2): 552-9, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25973914

ABSTRACT

AIMS: This study aimed to investigate the fate of Bacillus clausii spores orally administered as lyophilized or liquid formulation to healthy volunteers. METHODS AND RESULTS: The study was a randomized, open-label, cross-over trial in which two commercial probiotic formulations containing spores of four antibiotic-resistant B. clausii strains (OC, NR, SIN, T) were given as a single dose administration. Faecal B. clausii units of each strain were counted on selective media and extrapolated for the total weight of evacuated faeces. RAPD-PCR typing was used to confirm B. clausii identification. Bacillus clausii was found alive in faeces for up to 12 days. In some volunteers, the recovered amount of OC, NR or SIN was higher than the number of administered spores. Bioequivalence among the two formulations was demonstrated. CONCLUSIONS: Bacillus clausii spores survive transit through the human gastrointestinal tract. They can undergo germination, outgrowth and multiplication as vegetative forms. Bacillus clausii strains can have different ability to survive in the intestinal environment. Bacillus clausii spores administered as liquid suspension or lyophilized form behave similarly in vivo. SIGNIFICANCE AND IMPACT OF THE STUDY: This work contributes towards a better understanding of the behaviour of B. clausii spores as probiotics.


Subject(s)
Bacillus/growth & development , Gastrointestinal Tract/microbiology , Probiotics/administration & dosage , Administration, Oral , Adult , Bacillus/genetics , Cross-Over Studies , Feces/microbiology , Female , Humans , Male , Random Allocation , Random Amplified Polymorphic DNA Technique , Spores, Bacterial/genetics , Spores, Bacterial/growth & development
2.
Br J Dermatol ; 162(2): 311-7, 2010 Feb 01.
Article in English | MEDLINE | ID: mdl-19886884

ABSTRACT

BACKGROUND: Two nail lacquers, containing ciclopirox (CPX) or amorolfine (MRF), based on water-insoluble polymers are currently considered mainstays of topical treatment of onychomycosis. The present study aimed at evaluating the antimycotic activity of a new water-soluble nail lacquer containing CPX (CPX/sol), easily removable by washing with water and applicable to periungual skin. OBJECTIVES: To compare transungual permeation of CPX with that of MRF in the same hydroxypropyl chitosan-based nail lacquer (MRF/sol) and with a nonwater-soluble reference (Loceryl); Galderma International, La Défense, France), and to evaluate the antimycotic activity of CPX/sol and Loceryl against the most common fungal strains that cause onychomycosis. Methods In vitro drug permeation experiments with CPX/sol, MRF/sol and Loceryl were carried out through bovine hoof slices. Experimental permeates from CPX/sol and Loceryl underwent in vitro susceptibility testing against clinical isolates of dermatophytes, moulds and yeast. Results MRF transungual flux from MRF/sol lacquer was significantly higher when compared with Loceryl. CPX was able to permeate hoof membranes more easily compared with MRF. CPX and MRF concentrations in the subungual fluids collected after application of CPX/sol or Loceryl were sufficient to inhibit fungal growth, with the exception of Candida parapsilosis. Smaller amounts of fluid containing CPX were required for complete inhibition of fungal growth. Efficacy index values were significantly higher for CPX/sol. Conclusions Application of the CPX/sol nail lacquer allows rapid nail penetration of CPX, providing CPX levels sufficient to inhibit fungal growth for a prolonged period of time (30 h) after application of lacquer dose. CPX/sol nail lacquer appeared superior to the market reference Loceryl in terms of both vehicle (hydroxypropyl chitosan) and active ingredient (CPX) as witnessed by its higher efficacy on all nail pathogens.


Subject(s)
Antifungal Agents/administration & dosage , Lacquer , Morpholines/administration & dosage , Onychomycosis/drug therapy , Pyridones/administration & dosage , Absorption , Administration, Topical , Animals , Antifungal Agents/pharmacokinetics , Cattle , Ciclopirox , Hoof and Claw , Humans , Morpholines/pharmacokinetics , Nails , Onychomycosis/metabolism , Permeability , Pharmaceutical Solutions/administration & dosage , Pharmaceutical Vehicles , Pyridones/pharmacokinetics , Regression Analysis , Solubility
3.
Acta Physiol Hung ; 95(4): 419-24, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19009916

ABSTRACT

11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) is a NADPH dependent oxidoreductase of the endoplasmic reticulum lumen which converts cortisone to cortisol and plays a role in the pathogenesis of metabolic syndrome and type 2 diabetes. The aim of our study was to investigate the correlation between the expression/activity of 11betaHSDI and obesity. Liver and adipose tissue microsomes of an obese (Zucker) and a non-obese (Goto-Kakizaki) type 2 diabetes model rat strains were used. 11betaHSDI expression was detected at mRNA, protein and activity level. The activity of 11betaHSD1 was increased in the adipose tissue and decreased in the liver of the obese Zucker rat, while its mRNA levels were significantly different only in the adipose tissue. In diabetic Goto-Kakizaki rat both the expression and the activity of 11betaHSD1 were elevated in liver, but not in adipose tissue. These results suggest that the prereceptorial glucocorticoid activation is different in the liver and adipose tissue of the two diabetes models. This phenomenon might be responsible for the obese and lean phenotypes in type 2 diabetes.


Subject(s)
11-beta-Hydroxysteroid Dehydrogenase Type 1/genetics , 11-beta-Hydroxysteroid Dehydrogenase Type 1/metabolism , Body Weight , Diabetes Mellitus, Type 2/metabolism , Gene Expression Regulation, Enzymologic , Obesity/metabolism , Adipose Tissue/enzymology , Animals , Diabetes Mellitus, Type 2/genetics , Diabetes Mellitus, Type 2/physiopathology , Disease Models, Animal , Enzyme Activation , Glucocorticoids/metabolism , Liver/enzymology , Obesity/genetics , Obesity/physiopathology , RNA, Messenger/metabolism , Rats , Rats, Zucker
4.
J Appl Microbiol ; 97(6): 1220-7, 2004.
Article in English | MEDLINE | ID: mdl-15546413

ABSTRACT

AIMS: To compare the killing efficacy and the effects exerted by microwaves and conventional heating on structural and molecular components of Bacillus subtilis spores. METHODS AND RESULTS: A microwave waveguide applicator was developed to generate a uniform and measurable distribution of the microwave electric-field amplitude. The applicator enabled the killing efficacy exerted by microwaves on B. subtilis spores to be evaluated in comparison with conventional heating at the same temperature value. The two treatments produced a similar kinetics of spore survival, while remarkably different effects on spore structures were seen. The cortex layer of the spores subjected to conductive heating was 10 times wider than that of the untreated spores; in contrast, the cortex of irradiated spores did not change. In addition, the heated spores were found to release appreciable amounts of dipicolinic acid (DPA) upon treatment, while extracellular DPA was completely undetectable in supernatants of the irradiated spores. These observations suggest that microwave radiation may promote the formation of stable complexes between DPA and other spore components (i.e. calcium ions); thus, making any release of DPA from irradiated spores undetectable. Indeed, while a decrease in measurable DPA concentrations was not produced by microwave radiation on pure DPA solutions, a significant lowering in DPA concentration was detected when this molecule was exposed to microwaves in the presence of either calcium ions or spore suspensions. CONCLUSIONS: Microwaves are as effective as conductive heating in killing B. subtilis spores, but the microwave E-field induces changes in the structural and/or molecular components of spores that differ from those attributable only to heat. SIGNIFICANCE AND IMPACT OF THE STUDY: This study provides information on the effect of microwaves on B. subtilis spore components.


Subject(s)
Bacillus subtilis/radiation effects , Microwaves , Spores, Fungal/radiation effects , Bacillus subtilis/metabolism , Bacillus subtilis/ultrastructure , Calcium/metabolism , Enzyme Inhibitors/metabolism , Hot Temperature , Microscopy, Electron , Picolinic Acids/metabolism , Spores, Fungal/metabolism , Spores, Fungal/ultrastructure
5.
J Appl Microbiol ; 95(6): 1255-60, 2003.
Article in English | MEDLINE | ID: mdl-14632999

ABSTRACT

AIMS: Development of an agar-diffusion assay to measure vitamin B2 in biological samples and application of the method to determine the amount of vitamin B2 secreted by bacteria. METHODS AND RESULTS: A riboflavin-auxotrophic mutant of Bacillus cereus was generated by mini-Tn10 insertion in the ribD gene. ribD mutant sensitivity to exogenous vitamin B2 was investigated by turbidimetric and agar-diffusion assays. In turbidimetric assays, the B. cereus mutant displayed a similar level of sensitivity to vitamin B2 to that of Lactobacillus casei ATCC 7469, the reference organism used for microbiological vitamin B2 quantification. However, only the ribD mutant could be used as an indicator organism in agar-diffusion assays. A total of eight probiotic strains, from five different probiotic formulations, were analysed by the ribD mutant-based assay on agar plates in order to determine their ability to secrete vitamin B2 during growth. CONCLUSION: The agar diffusion method with the ribD mutant of B. cereus is highly reproducible, sensitive, rapid, inexpensive, and can be applied to measure the amount of vitamin B2 in different samples. SIGNIFICANCE AND IMPACT OF THE STUDY: The method developed in this study appears to be a good candidate for the screening of vitamin B2 secretion by bacteria growing on solid media.


Subject(s)
Bacillus cereus/metabolism , Probiotics/metabolism , Riboflavin/metabolism , Agar , Bacillus cereus/drug effects , Bacillus cereus/genetics , Bacillus cereus/growth & development , Bacteriological Techniques/methods , Culture Media , Dose-Response Relationship, Drug , Microbial Sensitivity Tests/methods , Mutagenesis, Insertional , Nephelometry and Turbidimetry , Riboflavin/genetics , Riboflavin/pharmacology
6.
Scand J Immunol ; 56(1): 43-51, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12100470

ABSTRACT

Mycobacterium tuberculosis (MTB) secretory proteins are generally considered important antigens for immune protection against tuberculosis (TB). An 8.3-kDa secretory antigen of MTB and Mycobacterium bovis bacillus Calmette-Guérin (BCG), called SA5K, was recently identified and cloned in our laboratory. In this report, recombinant SA5K containing a histidine hexamer was expressed in Escherichia coli and purified to investigate its biochemical structure and to establish whether it was immunogenic for healthy sensitized and nonsensitized human donors and for patients infected with MTB. The protein nucleotide sequence was shown to be identical in BCG and in MTB. SA5K revealed an abnormal electrophoretic mobility in SDS-PAGE that made it look lighter than it is in Western blotting. While recombinant SA5K was poorly recognized by T lymphocytes from patients with pulmonary TB, it elicited proliferation of CD4+ T lymphocytes in the vast majority of healthy individuals sensitized to mycobacterial antigens by BCG vaccination. At a serum dilution of 1 : 80, antibodies reacting against recombinant SA5K were found in 67% of sera from TB patients and in 73% of sera from healthy subjects. The percentage of positive subjects dropped at higher serum dilutions, but no significant difference in the recognition rate was observed between TB patients and healthy donors and between healthy vaccinated and nonvaccinated subjects. Owing to the high percentage of sera from healthy subjects who recognized SA5K in Western blotting, the antigen seems to exhibit, at least in the present form, a poor specificity for an employment for a serodiagnosis of TB.


Subject(s)
Antigens, Bacterial/immunology , Mycobacterium tuberculosis/immunology , Tuberculosis, Pulmonary/immunology , Antigens, Bacterial/genetics , Antigens, Bacterial/isolation & purification , B-Lymphocytes/immunology , Electrophoresis, Polyacrylamide Gel/methods , Escherichia coli , Genetic Vectors , Humans , Mycobacterium bovis/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/isolation & purification , T-Lymphocytes/immunology , Tuberculosis, Pulmonary/blood
7.
J Periodontol ; 72(9): 1151-6, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11577945

ABSTRACT

BACKGROUND: Non-steroidal anti-inflammatory drugs and antibiotics are important in the prevention of infections and pain associated with periodontal surgery as well as in the adjunctive therapy of periodontal disease. In this study, patients undergoing oral surgery were treated with piroxicam and azithromycin to examine the interactions of these drugs on periodontal tissues. METHODS: Sixty-six patients were assigned to 3 groups and treated for 3 days as follows: 1) piroxicam 20 mg/day; 2) azithromycin 500 mg/day; or 3) piroxicam 20 mg/day plus azithromycin 500 mg/day. Samples of blood, saliva, gingiva, and alveolar bone were collected during surgery and at days 0.5, 2.5, 4.5, and 6.5 after last dose. Piroxicam concentrations were assayed by high-performance liquid chromatography and azithromycin concentrations by microbiological assay. RESULTS: In patients treated with piroxicam alone, the highest drug concentrations were found in plasma at each time point, but consistent piroxicam levels were also detected in gingival samples up to 4.5 days. The combined treatment with piroxicam plus azithromycin was associated with a reduction of piroxicam concentrations in periodontal tissues. In patients receiving azithromycin alone, high drug levels were measured in periodontal tissues up to 6.5 days. This distribution pattern did not vary in patients treated with piroxicam plus azithromycin. CONCLUSIONS: Treatment with piroxicam or azithromycin alone ensures a favorable distribution of these drugs into periodontal tissues. However, upon combined administration, azithromycin interferes negatively with the periodontal disposition of piroxicam. This interaction might depend on the displacement of piroxicam from acceptor sites at the level of periodontal tissues.


Subject(s)
Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/pharmacokinetics , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Azithromycin/adverse effects , Azithromycin/pharmacokinetics , Piroxicam/pharmacokinetics , Adolescent , Adult , Anti-Bacterial Agents/blood , Anti-Inflammatory Agents, Non-Steroidal/blood , Azithromycin/blood , Drug Combinations , Drug Interactions , Female , Humans , Male , Middle Aged , Periodontium/metabolism , Piroxicam/blood , Saliva/metabolism , Time Factors , Tissue Distribution
8.
Eur J Clin Microbiol Infect Dis ; 20(8): 544-53, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11681433

ABSTRACT

This report describes the use of the 27A probe for the molecular monitoring of Candida albicans infections in liver transplant recipients. Nosocomial candidiasis is the major fungal infection in liver transplant recipients, with Candida albicans being the species most frequently isolated. The molecular epidemiology of Candida albicans infections has been widely investigated, but scant attention has been focused on monitoring the identity of infecting strains in individual patients over the entire course of their hospitalization. In the study presented here, a total of 179 Candida albicans isolates were collected from 10 liver transplant recipients during multiple surveillance cultures performed before and after liver transplantation and from three healthcare workers at the Transplant Unit of Ospedale di Cisanello, Pisa (Italy). Computer-aided analysis of the 27A-probed DNA fingerprints, used to compare the genetic relatedness of all the Candida albicans isolates, showed that most of the patients colonized with Candida albicans before transplantation harbored a unique Candida albicans genotype. This genotype persisted over the entire course of hospitalization and caused multiorgan failure in two patients, both of whom died from endogenously borne Candida albicans infections. Nosocomial acquisition of Candida albicans strains could be monitored in a timely manner in the other patients; for some of them, subsequent strain replacement was registered at different body sites during the post-transplant period. Neither cross-infection between patients nor transmission from healthcare workers to patients occurred in this hospital setting. These results indicate that the molecular monitoring of Candida albicans strains isolated from liver transplant recipients during their hospitalization may provide timely information about the identity of individual Candida albicans strains causing infections.


Subject(s)
Candida albicans/classification , Candida albicans/genetics , Candidiasis/microbiology , DNA Probes/genetics , Liver Transplantation/adverse effects , Adult , Aged , Blotting, Southern , Candida albicans/isolation & purification , Candidiasis/diagnosis , DNA Fingerprinting/methods , Digoxigenin/metabolism , Female , Humans , Male , Middle Aged , Species Specificity
9.
Minerva Chir ; 56(1): 93-5, 2001 Feb.
Article in Italian | MEDLINE | ID: mdl-11283485

ABSTRACT

The authors report the case of a female patient suffering from colic neoplasm and a vast peristomal laparocele, the long-term outcome of a rectal amputation that the patient underwent at a young age. After colic resection, a vast area of surgical mesh in dacron was modelled and positioned in a retromuscular scat, thus allowing the hernia pathology to be resolved relatively simply, owing to its particular location-in correspondence with a preternatural anus-until not long ago this would have represented an absolute contraindication to the use of prosthetic materials. A precise surgical approach, marked by a scrupulous respect for aseptic conditions, is essential in these circumstances owing to the persistent risk of septic complications.


Subject(s)
Colostomy/adverse effects , Hernia, Ventral/etiology , Hernia, Ventral/surgery , Surgical Mesh , Aged , Female , Humans
10.
Appl Environ Microbiol ; 67(2): 834-9, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11157251

ABSTRACT

A substantial number of Bacillus species have been marketed for use in oral bacteriotherapy because of their purported ability to prevent or treat various gastrointestinal disorders. Recently, some of the Bacillus strains in Enterogermina, which is made up of aqueous suspensions of viable Bacillus spores, have been partially characterized and aligned with members of the Bacillus alcalophilus subgroup rather than with Bacillus subtilis, as previously reported. With a view toward verifying the original taxonomic position of the Enterogermina strains, we catalogued both phenotypic and genotypic traits exhibited by the four Bacillus strains isolated from the spore mixtures found in original commercial preparations dated 1975 and 1984 and commercial preparations now being propagated industrially. Analyses of physiological and biochemical traits, complete 16S rRNA gene sequences, DNA-DNA reassociation, tRNA intergenic spacer length polymorphism, single-strand conformation polymorphism of PCR-amplified spacer regions of tRNA genes, and randomly amplified polymorphic DNA led to the finding that all of the Enterogermina strains belong to a unique genospecies, which is unequivocally identified as the alkalitolerant species Bacillus clausii. Moreover, we provide evidence that in contrast to several reference strains of B. clausii, the strains constituting Enterogermina are characterized by a notable low level of intraspecific genome diversity and that each strain has remained the same for the last 25 years.


Subject(s)
Bacillus/classification , Bacillus/genetics , Gastrointestinal Diseases/therapy , Probiotics/therapeutic use , Administration, Oral , Bacterial Typing Techniques , DNA, Bacterial/genetics , Genes, rRNA , Humans , Molecular Sequence Data , Nucleic Acid Hybridization , Phenotype , Polymerase Chain Reaction/methods , Polymorphism, Genetic , Polymorphism, Single-Stranded Conformational , RNA, Ribosomal, 16S/genetics , RNA, Transfer/genetics , Random Amplified Polymorphic DNA Technique , Spores, Bacterial/growth & development
11.
Antimicrob Agents Chemother ; 45(1): 356-8, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11120998

ABSTRACT

A reliable and low-cost method that enables rapid screening of the activity exerted by new antimicrobial agents on intracellularly growing Mycobacterium avium has been developed. To this aim, a recombinant (lacZ) strain of M. avium expressing the Escherichia coli beta-galactosidase gene was used to evaluate, in murine macrophages, the susceptibility of M. avium to common antimycobacterial agents. beta-Galactosidase levels, measured in the presence of each of the antibiotics tested, were closely correlated with the number of CFU recovered from the M. avium lacZ strain-infected macrophages.


Subject(s)
Macrophages/microbiology , Mycobacterium avium/drug effects , Mycobacterium avium/enzymology , beta-Galactosidase/metabolism , Animals , Colony-Forming Units Assay , Escherichia coli/genetics , In Vitro Techniques , Lac Operon , Macrophages/drug effects , Mice , Microbial Sensitivity Tests , Mycobacterium avium/genetics
12.
Eur J Oral Sci ; 109(6): 388-92, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11767275

ABSTRACT

Little is known about the effect of removable orthodontic appliances on oral colonisation by mutans streptococci (MS). In the present study, the frequency of isolation and serotype distribution of MS were evaluated in two groups of children, one undergoing therapy with removable appliances and the other not subjected to any kind of orthodontic treatment, respectively. Streptococci isolated from dental plaque samples from both groups of children were identified as mutans streptococci on the basis of their morphological and biochemical properties and were then serotyped in an enzyme immuno-assay using monoclonal antibodies. The number of subjects harbouring MS in their dental plaque was statistically higher in the group of orthodontic children without caries experience (CF) in comparison with CF children of the control group (10/12, 83.3% vs. 15/44, 34%). No clear difference was observed in the distribution of the different MS serotypes between the experimental and control group: S. mutans c,f serotype was the most frequently isolated in both groups of children followed by S. mutans serotype e and S. sobrinus serotype g. Such results suggest that the use of removable appliances may lead to the creation of new retentive areas and surfaces, which favour the local adherence and growth of MS. The data obtained stress the importance of a careful monitoring of patients treated orthodontically for risk of caries development.


Subject(s)
Dental Caries/etiology , Dental Plaque/microbiology , Orthodontic Appliances, Removable/adverse effects , Streptococcus mutans , Case-Control Studies , Chi-Square Distribution , Child , Colony Count, Microbial , Dental Caries/microbiology , Female , Humans , Male , Serotyping , Streptococcus mutans/classification , Streptococcus mutans/isolation & purification
13.
J Antimicrob Chemother ; 46(5): 831-4, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11062209

ABSTRACT

This report describes the efficacy of a novel mucoadhesive polymer, the tamarind seed polysaccharide, as a delivery system for the ocular administration of hydrophilic and hydrophobic antibiotics. Healthy rabbits were subjected to repeated ocular instillations with either conventional gentamicin or ofloxacin or these agents viscosified with the tamarind seed polysaccharide. Administration of viscosified preparations produced antibiotic concentrations both in the aqueous humour and cornea that were significantly higher than those achieved with the drugs alone. The increased drug absorption and the prolonged drug elimination phase obtained with the viscosified formulations indicate the usefulness of the tamarind seed polysaccharide as an ophthalmic delivery system for topical administration of antibiotics.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Anti-Infective Agents/pharmacokinetics , Aqueous Humor/metabolism , Gentamicins/pharmacokinetics , Glycosaminoglycans/pharmacokinetics , Ofloxacin/pharmacokinetics , Administration, Topical , Animals , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Drug Delivery Systems/methods , Drug Interactions , Eye Infections/drug therapy , Gentamicins/therapeutic use , Glycosaminoglycans/therapeutic use , Male , Ofloxacin/therapeutic use , Phytotherapy , Rabbits , Seeds/therapeutic use
14.
Antimicrob Agents Chemother ; 44(12): 3257-63, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11083624

ABSTRACT

In light of the need for new antifungal agents, the candidacidal activities of human lactoferrin (hLF) and synthetic peptides representing the first, hLF(1-11), and second, hLF(21-31), cationic domains of its N terminus were compared. The results revealed that hLF(1-11) was more effective in killing fluconazole-resistant Candida albicans than hLF(21-31) and much more effective than lactoferrin, as determined microbiologically and by propidium iodide (PI) staining. By using hLF(1-11) and various derivatives, it was found that the second and third residues of the N terminus of hLF(1-11) were critical for its candidacidal activity. Detailed investigation to elucidate the mechanism of action of hLF(1-11) revealed a dose-dependent release of ATP by Candida upon exposure to hLF(1-11). Our observations that sodium azide reduced the PI uptake and candidacidal activity of hLF(1-11) and that, upon exposure to hLF(1-11), the fluorescent dye rhodamine 123 first accumulated inside the mitochondria and later was released into the cytoplasm indicate that the peptide triggers the energized mitochondrion. Furthermore, oxidized ATP, which interferes with the interaction of ATP with its extracellular receptors, blocked the candidacidal action of hLF(1-11), as measured microbiologically and by PI staining. Addition of ATP (or analogues) was not a sufficient stimulus to kill C. albicans or to act synergistically with suboptimal concentrations of the peptide. The main conclusions are that the first two arginines at the N terminus of hLF are critical in the candidacidal activity of hLF(1-11) and that extracellular ATP is essential but not sufficient for the peptide to exert its candidacidal activity.


Subject(s)
Adenosine Triphosphate/analogs & derivatives , Antifungal Agents/pharmacology , Candida albicans/drug effects , Lactoferrin/pharmacology , Adenosine Triphosphate/metabolism , Adenosine Triphosphate/pharmacology , Binding Sites , Candida albicans/metabolism , Cell Membrane Permeability/drug effects , Colony-Forming Units Assay , Drug Interactions , Drug Resistance, Microbial , Enzyme Inhibitors/pharmacology , Fluconazole/pharmacology , Humans , Intracellular Membranes/drug effects , Intracellular Membranes/metabolism , Lactoferrin/analogs & derivatives , Mitochondria/drug effects , Mitochondria/metabolism , Peptides/pharmacology , Protein Conformation , Sodium Azide/pharmacology , Technetium
15.
FEMS Microbiol Lett ; 190(2): 247-53, 2000 Sep 15.
Article in English | MEDLINE | ID: mdl-11034287

ABSTRACT

This paper describes the first identification of chemotaxis genes in Bacillus cereus. We sequenced and studied the genomic organization and the expression of the cheA and fliY genes in two different B. cereus strains, ATCC 14579 and ATCC 10987. While cheA encodes a highly conserved protein acting as the main regulator of the chemotactic response in flagellated eubacteria, fliY, which has been previously described only in B. subtilis, is one of the three genes encoding proteins of the flagellar switch complex. Although the sequences and relative position of cheA and fliY were found to be identical in the two B. cereus strains analyzed, the restriction fragment containing both genes was located differently on the physical maps of B. cereus ATCC 14579 and ATCC 10987. Evidence is shown that the genomic organization and the expression of fliY and cheA in B. cereus differ significantly from that described for B. subtilis, which is considered a model microorganism for chemotaxis in gram-positive bacteria.


Subject(s)
Bacillus cereus/genetics , Bacillus cereus/physiology , Bacterial Proteins/genetics , Chemotaxis/genetics , Membrane Proteins/genetics , Amino Acid Sequence , Bacterial Proteins/metabolism , Chemotaxis/physiology , DNA, Complementary/genetics , Electrophoresis, Gel, Pulsed-Field , Genomic Library , Membrane Proteins/metabolism , Methyl-Accepting Chemotaxis Proteins , Molecular Sequence Data , Physical Chromosome Mapping , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA
16.
Clin Exp Immunol ; 119(2): 270-9, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10632662

ABSTRACT

In order to investigate the ability of Mycobacterium bovis BCG vaccination to induce immune responses toward different classes of mycobacterial antigens and the cell populations involved in such responses, proliferation of distinct human lymphocyte subsets from BCG-vaccinated donors in response to different subcellular fractions of BCG was analysed and compared with that of not sensitized subjects. Proliferation of different cell subsets was evaluated by flow cytometric determination of bromodeoxyuridine incorporated into DNA of dividing cells and simultaneous identification of cell surface markers. Although a certain degree of variability was observed among different donors, after 6 days of in vitro stimulation BCG-vaccinated subjects displayed, as a mean, a stronger blastogenic response to all the classes of antigens compared with non-sensitized ones. PPD, culture filtrates and membrane antigens induced a predominant proliferation of CD4+ T cells. In contrast, preparations enriched in cytosolic antigens elicited strong proliferation of gammadelta+ T cells which, as a mean, represented 55% of the proliferating cells. Although to a lesser extent, proliferation of gammadelta+ T cells was also elicited by preparations enriched in membrane and cell wall antigens. In response to the latter preparation proliferation of CD4+ T cells and CD16+/CD3- (natural killer (NK)) cells was observed, as well. In particular, cell wall antigens were found to induce significantly higher levels of proliferation of NK cells compared with all the other classes of antigens.


Subject(s)
BCG Vaccine/immunology , Lymphocyte Activation/immunology , Mycobacterium bovis/immunology , T-Lymphocyte Subsets/immunology , Adult , Antigens, Bacterial/administration & dosage , Antigens, Bacterial/classification , Antigens, Bacterial/immunology , BCG Vaccine/administration & dosage , Cells, Cultured , Flow Cytometry , Humans , Interferon-gamma/biosynthesis , Mycobacterium bovis/ultrastructure , Subcellular Fractions/immunology , Subcellular Fractions/microbiology , T-Lymphocyte Subsets/microbiology , Vaccination
17.
J Periodontol ; 70(9): 960-6, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10505797

ABSTRACT

BACKGROUND: The recognition that periodontal diseases are associated with specific pathogens has led to interest in the use of antibacterial drugs for inhibition of these microorganisms. On these bases, the present study was aimed at evaluating the tissue distribution of the new macrolide antibiotic azithromycin in patients subjected to oral surgery for chronic inflammatory diseases of both marginal and periapical periodontium. METHODS: Thirty-two patients were treated with azithromycin 500 mg/day orally for 3 consecutive days, and drug concentrations in plasma, saliva, normal gingiva, and pathological periodontal tissues were evaluated. For this purpose, samples of blood, saliva, normal gingiva, granulation tissue, and radicular granuloma or cyst wall (from dentigerous cyst) were collected during oral surgery or 0.5, 2.5, 4.5, and 6.5 days after the end of pharmacological treatment; then, azithromycin levels were measured by a microbiological plate assay, using Micrococcus luteus NCTC 8440 as the indicator organism. RESULTS: The concentrations of azithromycin in plasma, saliva, normal gingiva, and pathological tissues reached the highest values 12 hours after the last dose (0.37+/-0.05 mg/l, 2.12+/-0.30 mg/l, 6.30+/-0.68 mg/kg, and 11.60+/-1.50 mg/kg, respectively) and then declined gradually. Consistent levels of the drug in normal gingiva and pathological tissues could be detected, however, up to 6.5 days, indicating that azithromycin was retained in target tissues for a long time after the end of treatment. Moreover, azithromycin levels in both normal gingiva and pathological tissues exceeded the minimum inhibitory concentrations of most pathogens involved in the pathophysiology of chronic inflammatory periodontal diseases. Notably, azithromycin levels in pathological tissues were significantly higher than those in normal gingiva 0.5, 2.5, and 4.5 days after the last dose. CONCLUSIONS: The present results indicate a marked penetration of azithromycin into both normal and pathological periodontal tissues, suggesting that azithromycin represents a promising option in both adjunctive and prophylactic treatments of chronic inflammatory periodontal diseases.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Periodontitis/drug therapy , Periodontium/metabolism , Adolescent , Adult , Anti-Bacterial Agents/blood , Anti-Bacterial Agents/pharmacokinetics , Azithromycin/blood , Azithromycin/pharmacokinetics , Chronic Disease , Dentigerous Cyst/metabolism , Dentigerous Cyst/surgery , Female , Follow-Up Studies , Gingiva/metabolism , Granulation Tissue/metabolism , Humans , Male , Microbial Sensitivity Tests , Micrococcus/drug effects , Middle Aged , Periapical Granuloma/metabolism , Periapical Granuloma/surgery , Periapical Periodontitis/drug therapy , Periapical Periodontitis/metabolism , Periapical Periodontitis/surgery , Periapical Tissue/metabolism , Periodontitis/metabolism , Periodontitis/surgery , Saliva/metabolism , Tissue Distribution
18.
Minerva Chir ; 54(6): 425-31, 1999 Jun.
Article in Italian | MEDLINE | ID: mdl-10479863

ABSTRACT

Two cases of Spigelian hernia are reported. Starting from the analysis of these cases, some observations about the anatomy, the etiology, clinic, diagnostic methods and the best therapeutic choices now available for this uncommon pathology are presented.


Subject(s)
Hernia, Ventral/surgery , Aged , Aged, 80 and over , Hernia, Ventral/diagnosis , Hernia, Ventral/diagnostic imaging , Humans , Male , Polypropylenes , Prosthesis Implantation , Tomography, X-Ray Computed
19.
FEMS Microbiol Lett ; 169(1): 117-24, 1998 Dec 01.
Article in English | MEDLINE | ID: mdl-9851042

ABSTRACT

A clinical isolate of Mycobacterium avium was transformed with a new shuttle plasmid containing the Escherichia coli beta-galactosidase reporter gene under the control of the Mycobacterium bovis bacillus Calmette-Guérin (BCG) hsp60 promoter. beta-Galactosidase activity was assayed spectrophotometrically in bacterial homogenates of the recombinant strain (M. avium::lacZ) and used for quantification of the hsp60 promoter strength in different conditions of extra- and intracellular growth. Very low levels of beta-galactosidase were recorded during the exponential phase of in vitro growth, while they increased progressively during the late exponential and stationary phases. A significant increase in enzyme activity was also induced in exponentially growing cells by shifting the incubation temperature from 37 to 45 degrees C, but not from 37 to 42 degrees C nor from 30 to 42 degrees C. No induction of the promoter was observed by adding hydrogen peroxide to the cultures. Finally, beta-galactosidase levels were quantified during growth of M. avium::lacZ in murine macrophages. Soon after phagocytosis and, to a lesser extent at 1, 5 and 7 days after infection, increased levels of bacterial beta-galactosidase were observed indicating an increment in transcriptional activity of hsp60 promoter both at early phases of infection and during the course of intracellular growth.


Subject(s)
Chaperonin 60/genetics , Mycobacterium avium/genetics , Mycobacterium bovis/genetics , Promoter Regions, Genetic , Animals , Female , Genes, Reporter , Heat-Shock Response , Lac Operon , Macrophages/cytology , Macrophages/microbiology , Mice , Mice, Inbred BALB C , Mycobacterium avium/growth & development , Oxidative Stress , Spleen/cytology , Spleen/microbiology
20.
Res Microbiol ; 149(4): 265-75, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9766228

ABSTRACT

A novel protein called SA-5K was identified in Mycobacterium bovis BCG (BCG) short-term culture filtrates (CFs) by means of a recently described monoclonal antibody (mAb), L8D8. This protein had an apparent molecular mass (MM) of 5 kDa, as judged by Western blotting after sodium dodecyl sulphate-polyacrylamide gel electrophoresis in reducing conditions, and did not seem to contain any sugar or lipid substituents. In the present work, SA-5K was purified from BCG CFs by affinity chromatography. A protein that could be detected in Western blot but not by standard protein staining techniques was obtained. When SA-5K was subjected to aminoterminal sequencing, the 10 amino acids (aa) found matched the first 10-aa sequence deduced from an open reading frame (ORF) of M. tuberculosis. The ORF encodes a polypeptide, likely to include a signal for secretion, with an estimated MM of 8.3 kDa after signal peptide cleavage. The secretory nature of SA-5K was confirmed by the fact that it could only be detected in CFs, but not in other BCG subcellular fractions. After size exclusion chromatography, reactivity with mAb L8D8 was found to peak in the 45-50- and 14-16-kDa fractions. The latter MM was close to that estimated from the ORF of M. tuberculosis, implying that the 5-kDa antigen detected initially by Western blot in reducing conditions was a portion of SA-5K released after reduction of a disulphide bridge. The presence of the gene for SA-5K in BCG and its identity were confirmed by PCR (polymerase chain reaction) with specific primers and restriction analysis: the PCR product was slightly shorter in BCG than in M. tuberculosis. The gene coding for SA-5K was cloned by PCR from BCG and M. tuberculosis DNA and was expressed in Escherichia coli.


Subject(s)
Antigens, Bacterial/genetics , Mycobacterium bovis/immunology , Mycobacterium tuberculosis/immunology , Amino Acid Sequence , Antigens, Bacterial/chemistry , Base Sequence , Cloning, Molecular , DNA, Bacterial/chemistry , Molecular Sequence Data , Molecular Weight , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...